110 likes | 113 Vues
According to the latest report by IMARC Group, the global pain management drugs market reached a value of US$ 74 Billion in 2020.u00a0<br>Pain management drugs are a set of medications that are used for reducing or treating the pain associated with a disease, injury or surgery. These drugs provide relief by acting through distinctive physiological mechanisms. <br>
E N D
Global Pain Management Drugs Market Research Report and Forecast 2021- 2026 Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2019 IMARC All Rights Reserved
Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value challenges, and transform their businesses. opportunities, address their most critical IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Report Description and Highlights Report Description Global Pain Management Drugs Market Outlook 2026: The latest report by IMARC Group, titled “Pain Management Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, finds that the global pain management drugs market reached a value of US$ 74 Billion in 2020. Pain management drugs are a set of medications that are used for reducing or treating the pain associated with a disease, injury or surgery. These drugs provide relief by acting through distinctive physiological mechanisms. The management of pain remains of high relevance across a broad spectrum of medical fields as it is one of the most common concerns for physicians while dealing with severe medical conditions. Owing to this, pain management medicines have evolved into a large specialty area over the years. Request for a free sample report: https://www.imarcgroup.com/pain-management-drugs- market/requestsample
Report Description and Highlights Report Description Global Pain Management Drugs Market Trends: The increasing prevalence of chronic conditions, such as lower back pain, post-operative pain, osteoarthritis and migraine headache, is the primary factor for the increase in the sales of pain management drugs across the globe. Also, these painkillers help the rising number of cancer patients to minimize pain during chemotherapy, radiotherapy, and surgeries involved in the treatment. Apart from this, governments of various nations are also providing funds to improve healthcare services. This has led to several medical advancements, resulting in the introduction of novel molecule combinations and newer drug delivery techniques. Moreover, the leading pharmaceutical companies are heavily investing in research and development (R&D) activities to develop analgesics that are safer, more effective, economically viable and easier to administer.
Report Description Report Description and Highlights Market Summary: Breakup by Drug Class: • NSAIDs • Anesthetics • Anticonvulsants • Antimigraine Agents • Antidepressants • Opioids Breakup by Distribution Channel: • Hospital Pharmacies • Retail Pharmacies • Online Pharmacies Breakup by Region: • Asia Pacific • North America • Europe • Middle East and Africa • Latin America
Report Description Report Description and Highlights Breakup by Indication: • Musculoskeletal Pain • Surgical and Trauma Pain • Cancer Pain • Neuropathic Pain • Migraine Pain • Obstetrical Pain • Fibromyalgia Pain • Burn Pain • Dental/Facial Pain • Pediatric Pain • Others On account of the aforementioned factors, the market is anticipated to witness strong growth during 2021-2026.
Report Description Report Description and Highlights Competitive Landscape With Keyplayer: • Abbott Laboratories Inc. • Pfizer Inc. • Eli Lilly & Company • Endo International plc • F. Hoffmann-La Roche AG • Bausch Health Companies Inc. • Merck & Co. Inc. • Allergen Inc. • Novartis International AG • Johnson & Johnson Private Limited • GlaxoSmithKline Plc • Purdue Pharma L.P. View Report TOC, Figures and Tables: https://www.imarcgroup.com/pain-management-drugs- market
We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients
We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients
Report Description and Highlights Report Description © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com